Appointments
+(603) 5515 1966
General Line
+(603) 5515 1888
August 4, 2026
An HPV diagnosis can feel alarming, especially when cervical cancer is the first thing that comes to mind. The reassuring truth is that having HPV does not mean you will develop cervical cancer. Most HPV infections clear on their own, often within about two years. The real concern is persistent infection with high-risk HPV types, which can cause abnormal cell changes in the cervix over time and, if left undetected and untreated, may lead to cervical cancer.
That distinction matters. HPV is very common, and in many cases, it causes no symptoms at all. In fact, most sexually active people will be exposed to HPV at some point. What determines risk is not simply whether HPV is present, but which type, how long it stays in the body, and whether screening picks up cell changes early.
Human papillomavirus, or HPV, is a group of viruses that can infect the skin and the lining of different parts of the body, including the cervix. Some HPV types are considered low-risk, meaning they may cause warts but are not linked to cancer. Others are high-risk and are strongly associated with cancers of the cervix, anus, vagina, vulva, penis, and parts of the throat.
Cervical cancer is one of the clearest examples of this connection. Nearly all cervical cancer cases are linked to HPV infection, particularly high-risk types. But HPV alone is not the whole story. In most people, the immune system clears the virus naturally. Cervical cancer usually develops only when a high-risk HPV infection persists and causes abnormal cervical cells to slowly change over a number of years.
This long timeline is important because it creates a major window for prevention. Screening tests can identify HPV infection or detect abnormal cells before cancer develops. That is why a positive HPV test should be seen as a signal for follow-up, not as a cancer diagnosis.
Not all HPV infections carry the same meaning. Low-risk HPV types are usually linked to genital warts and do not cause cervical cancer. High-risk HPV types are the ones doctors watch more closely because they can trigger cell changes that may become precancerous.
13 HPV types can cause cervical cancer. Some of these high-risk types are also linked to other cancers. If a test shows high-risk HPV, it does not mean cancer is present. It means the person may need closer monitoring, repeat testing, or further evaluation depending on age, screening history, and test results.
This is where patient education often makes the biggest difference. Many people hear “HPV positive” and assume the worst. In reality, most HPV infections resolve without treatment. The body’s immune system clears them before they can cause lasting harm.
Cancer risk rises when the infection does not go away. According to research, about 10% of women with HPV infection on the cervix will develop long-lasting infections that place them at higher risk for cervical cancer. Persistent infection, rather than one isolated positive result, is the issue clinicians pay attention to.
The short answer is yes, but not equally for everyone. An HPV diagnosis can increase the risk of cervical cancer if it involves a high-risk type and if the infection persists over time. A single HPV diagnosis, especially without abnormal cell changes, does not mean cancer is likely.
A better way to frame it is, HPV is a risk factor, not a prediction. It raises concern because cervical cancer is caused by long-term infection with oncogenic HPV types. Yet the progression from infection to precancer to cancer is usually slow, and there are multiple opportunities to detect and treat changes early.
For patients, this means the next step matters more than panic. If HPV is detected, proper follow-up may include repeat HPV testing, a Pap smear, or colposcopy, depending on the clinical context. In other words, the diagnosis increases risk, but screening and follow-up dramatically reduce the chance that risk turns into cancer.
HPV is the main cause, but several factors can increase the likelihood that an HPV infection will persist or progress.
This is the most important factor. A short-term infection is common. A persistent high-risk infection is what places cervical cells under prolonged stress and increases the chance of abnormal changes becoming precancerous or cancerous.
People with weakened immune systems may have more difficulty clearing HPV. This includes those living with HIV or people taking medications that suppress the immune system. Reduced immune response can allow HPV to persist longer and raise the risk of cervical abnormalities.
Smoking is a well-established risk factor for many cancers, and it also appears to contribute to cervical cancer risk. It can weaken local immune defences and may make it harder for the body to clear HPV-related changes effectively.
One of the biggest preventable risks is not being screened regularly. Screening helps detect precancerous changes before they become dangerous. Many cervical cancer deaths in the are prevented through widespread screening
Vaccination significantly lowers the risk of infection from the HPV types most commonly associated with cervical cancer. Current vaccines are designed to protect against HPV types responsible for about 90% of cervical cancers.
The progression from HPV infection to cervical cancer is usually gradual. This makes the disease one of the most preventable cancers when screening is accessible and used consistently.
| Stage | What Happens | Why It Matters |
|---|---|---|
| HPV exposure | The virus infects cervical cells | Infection is common and often temporary |
| Persistent infection | High-risk HPV remains in the cervix | Ongoing infection raises concern |
| Cell changes | Abnormal cells begin to form | These changes may be precancerous |
| Precancer | Cervical lesions become more significant | Treatment can prevent cancer |
| Cervical cancer | Abnormal cells invade deeper tissue | Early diagnosis improves outcomes |
In many people with healthy immune systems, progression can take 15 to 30 years. In people with compromised immunity, the process may be faster. That long window is exactly why HPV testing and Pap screening are so powerful.
HPV often causes no symptoms at all, particularly when it affects the cervix. That is why relying on symptoms is risky. A person can have high-risk HPV or early abnormal cervical changes and feel completely well.
Early cervical cancer and precancer also often produce no obvious symptoms. As disease becomes more advanced, warning signs may include:
These symptoms do not automatically mean cervical cancer, but they do warrant medical evaluation. Because symptoms tend to appear later, screening remains more reliable than waiting for signs to develop.
A positive HPV test can be emotionally difficult, but it should be approached calmly and practically. In most cases, the next steps involve monitoring rather than urgent treatment.
Management depends on your age, whether the HPV type is high-risk, and whether there are abnormal Pap results. Some patients need repeat testing in a year. Others may need further examination such as a colposcopy. The key is not to skip follow-up appointments.
This is one of the most important messages for patient reassurance. HPV positive is not the same as cervical cancer. It means your care team is identifying risk early, which is exactly what screening is supposed to do.
Cervical cancer prevention works best when follow-up is timely. If your hospital or clinic recommends repeat testing, Pap smear, HPV DNA testing, or referral to a gynaecologist, act on it promptly.
While no lifestyle change can “cure” HPV overnight, healthy habits can support immune function. Smoking cessation, good nutrition, managing chronic conditions, and attending preventive care appointments all matter.
Regular cervical cancer screening is one of the most effective ways to detect abnormal cervical cell changes early and reduce the risk of cervical cancer. In Malaysia, women can undergo a Pap smear, an HPV test, or both, depending on their age, medical history, and risk factors. Even if you have received the HPV vaccine, routine screening remains an essential part of preventive care.
If you are looking for cervical cancer screening in Malaysia, HPV testing, or a Pap smear, Avisena Specialist Hospital 2 offers comprehensive care through its General Obstetrics and Gynaecology department, with seamless referral to the Gynae Oncology team for further assessment and treatment when needed. Learn more about our General Obstetrics and Gynaecology services or our specialised Gynae Oncology services and book your screening today.
Vaccination is one of the strongest tools available for reducing cervical cancer risk. The HPV vaccine protects against the strains most closely linked to cervical cancer and several other HPV-related cancers. Evidence continues to show that vaccination is making a measurable difference.
That said, vaccination does not eliminate the need for screening. Current vaccines do not cover every high-risk HPV strain. This is why experts continue to recommend cervical screening even for vaccinated individuals.
While prevention remains the best strategy, cervical cancer research is moving forward quickly. The American Cancer Society notes ongoing work in immunotherapy, targeted therapy, radiation approaches, and chemotherapy combinations for cervical cancer treatment. Therapeutic vaccines are also being studied to help people who already have HPV-related disease.
A recent review in Genes & Diseases highlights promising research into DNA vaccines, CRISPR-based approaches, immune checkpoint inhibitors, and more personalized treatment strategies for HPV-driven cancers. These developments are exciting, but they do not replace the need for vaccination, screening, and early intervention today.
An HPV diagnosis can raise the risk of developing cervical cancer, but it does not mean cancer is inevitable. The highest risk lies with persistent high-risk HPV infections, especially when screening is delayed or missed. The encouraging news is that cervical cancer is often preventable through HPV vaccination, regular screening, and timely follow-up care.
The most important next step is simple, do not ignore the result, and do not panic. Get the right follow-up, stay up to date with cervical screening, and talk to a healthcare professional about vaccination and women’s health screening options available locally.
No. Most HPV infections do not lead to cervical cancer. The risk is higher when a high-risk HPV infection persists over time and causes abnormal changes in cervical cells.
It often takes many years. In people with healthy immune systems, the process may take 15 to 30 years, though it can happen faster in those with weakened immunity.
In many cases, yes. Regular screening, timely follow-up, and treatment of precancerous changes can prevent cervical cancer from developing.
Yes. HPV is extremely common, and most sexually active people will be exposed at some point in life. Many never know they had it because it often causes no symptoms.
Yes. The HPV vaccine offers strong protection, but it does not cover every cancer-causing HPV type. Screening remains important.
Sources:
Spread the love, follow us on our social media channels